VSI Spring 2023 Newsletter
Bibliography and Sources
Business Wire. Incyte Announces Long-Term Extension Data from Phase 3 TRuE-V Program Demonstrating Long-Term Safety and Durability of Response of Opzelura® (Ruxolitinib) Cream in Vitiligo. Businesswire.com. 2023 March 18.
Gray, L. If You Notice This on Your Fingernails, Get a Blood Test. Bestlifeonline.com. 2022 Mar 28. https://bestlifeonline.com/pitted-fingernails-autoimmune-condition-news/
Irfan M, Ali Azfar N, et al. Frequency and types of nail changes in patients of vitiligo: Journal of Pakistan Association of Dermatologists. 2021;31(2):173-178. https://www.jpad.com.pk/index.php/jpad/article/view/1608/1550
New Health Advisor. No Moons on Fingernails. Newhealthadvisor.com. 2014. http://www.newhealthadvisor.com/No-Moons-on-Fingernails.html
Rosmarin D, Passeron T, Pandya AG, et al. Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo. N Engl J Med. 387(16):1445-1455. 2022 Oct 20. https://pubmed.ncbi.nlm.nih.gov/36260792/
Topal IO, Gungor S, et al. Nail abnormalities in patients with vitiligo. An Bras Dermatol. 2016;91(4):442-5. https://www.ncbi.nlm.nih.gov/pubmed/27579738
van Mensvoort M. Hand Research Nail Tutor: Lunula. Handresearch.com. http://www.handresearch.com/finger-nails/nail-tutor-lunula-missing-absent.htm
Copyright © 2023 Vitiligo Support International Inc. All rights reserved.
Reproduction or republication strictly prohibited without prior written permission.
A Vitiligo Support International, Inc. financial statement is available upon written request from the Virginia Office of Consumer Affairs. Mail requests to: Virginia Department of Agriculture and Consumer Services, Office of Consumer Affairs, P.O. Box 1163, Richmond, Virginia 23218.